Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/handle/10553/48627
DC FieldValueLanguage
dc.contributor.authorNeth, Olaf Werneren_US
dc.contributor.authorFalcon, Doloresen_US
dc.contributor.authorPeromingo, Estrellaen_US
dc.contributor.authorSoledad Camacho, Mariaen_US
dc.contributor.authorRodríguez-Gallego, Carlosen_US
dc.contributor.authorObando, Ignacioen_US
dc.date.accessioned2018-11-23T23:31:28Z-
dc.date.available2018-11-23T23:31:28Z-
dc.date.issued2011en_US
dc.identifier.issn0891-3668en_US
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/48627-
dc.description.abstractWe present a 3-year-old girl who had chronic recurrent multifocal osteomyelitis caused by Coxiella burnetii despite long-term dual antibiotic therapy. Excellent clinical response was achieved and sustained when immunomodulatory therapy with interferon-γ was initiated. This is the case of a first child who was successfully treated with interferon-γ as adjuvant therapy for chronic multifocal Q fever osteomyelitis.en_US
dc.languageengen_US
dc.relation.ispartofPediatric Infectious Disease Journalen_US
dc.sourcePediatric Infectious Disease Journal[ISSN 0891-3668],v. 30, p. 810-812 (Septiembre 2011)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320505 Enfermedades infecciosasen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherOsteomyelitisen_US
dc.subject.otherQ Feveren_US
dc.titleSuccessful management of chronic multifocal Q fever osteomyelitis with adjuvant interferon-gamma therapyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/INF.0b013e31821487f5en_US
dc.identifier.scopus80051926979-
dc.contributor.authorscopusid6506737455-
dc.contributor.authorscopusid50161326000-
dc.contributor.authorscopusid15036588100-
dc.contributor.authorscopusid36998670900-
dc.contributor.authorscopusid6602114379-
dc.contributor.authorscopusid6602945227-
dc.description.lastpage812en_US
dc.description.firstpage810en_US
dc.relation.volume30en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages3en_US
dc.utils.revisionen_US
dc.date.coverdateSeptiembre 2011en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,745-
dc.description.jcr3,577-
dc.description.sjrqQ1-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

17
checked on Mar 30, 2025

WEB OF SCIENCETM
Citations

17
checked on Mar 30, 2025

Page view(s)

49
checked on May 18, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.